Metraipolis › archive › dc_664ce6edf3ee
Ceftazidime-Avibactam as Early Empiric Therapy for Gram-Negative Nosocomial Infections: A Risk-Stratified Empiric Use Informed by National AMR Surveillance… — Europe PMC PMID:42505656
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42505656
- DOI
- 10.3390/antibiotics15070693
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T10:38:42.772Z
- SHA-256 of the archived text
57611ea67ebf0d34fed73c4e902097c710666d87fc4ec35e4ad6ed1fca87719f- Stable URL of this page
https://metraipolis.com/documento/dc_664ce6edf3ee
How to cite
Ceftazidime-Avibactam as Early Empiric Therapy for Gram-Negative Nosocomial Infections: A Risk-Stratified Empiric Use Informed by National AMR Surveillance… — Europe PMC PMID:42505656 — Europe PMC (en), https://europepmc.org/article/MED/42505656 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_664ce6edf3ee (Metraipolis archive dc_664ce6edf3ee, sha256 57611ea67ebf0d34fed73c4e902097c710666d87fc4ec35e4ad6ed1fca87719f)
BibTeX
@misc{dc664ce6edf3ee,
title = {Ceftazidime-Avibactam as Early Empiric Therapy for Gram-Negative Nosocomial Infections: A Risk-Stratified Empiric Use Informed by National AMR Surveillance… — Europe PMC PMID:42505656},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42505656},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_664ce6edf3ee; sha256 57611ea67ebf0d34fed73c4e902097c710666d87fc4ec35e4ad6ed1fca87719f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42505656. Agents can read the archived copy with the MCP tool read_document.